Back to results
US 2025/0152630 A1Published application
Methods for the production of tcr gamma delta + t cells
AssigneeGammaDelta Therapeutics Ltd
InventorsDiogo Antonio Remechido ANJOS, Daniel Vargas CORREIA, Afonso Rocha MARTINS DE ALMEIDA
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel methods for the isolation and the selective ex vivo expansion of Vδ2− TCRγδ+ T cells and to their clinical application.
Claims40
A method for expanding Vδ2−TCRγδ+ T cells in a sample comprising:
- culturing cells in the sample in a culture medium comprising a T cell mitogen which is an antibody or fragment thereof and interleukin-4;
- in the absence of a interleukin-15 and in the absence of feeder cells;
- or
- culturing the cells in the sample in a culture medium comprising a T cell mitogen which is an antibody or fragment thereof and interleukin-15, in the absence of interleukin-4 and in the absence of feeder cells.
1 more element
2-4. (canceled)
15-18. (canceled)
(canceled)
24-26. (canceled)
28-30. (canceled)
32-35. (canceled)
38-40. (canceled)
42-44. (canceled)
(canceled)
49-51. (canceled)
53-58. (canceled)
Dependencies are inferred from the claim text.